Brochure-backed pellet portfolio for multiparticulate delivery systems, modified release development, and high-uniformity fill applications.
| Sr. No. | Name of Product | Strengths (% w/w) | BCS Class | Pharmacological category |
|---|---|---|---|---|
| Immediate Release Pellets | ||||
| 1 | Atorvastatin Pellets | 7.5, 10, 15, 20 | Class-II | Antihyperlipidemic agent |
| 2 | Ciprofloxacin HCl Pellets | 20 | Class-IV | Quinolone Antibiotic |
| 3 | Clopidogrel Pellets | 28.832, 29.119, 40, 50 | Class-II | Antiplatelet agent |
| 4 | Dabigatran Etexilate Pellets | 35, 40, 43, 50 | Class-II | Anticoagulant |
| 5 | Domperidone Pellets | 7, 7.5, 10, 12.5, 20, 30, 40 | Class-II | Antiemetic agent |
| 6 | Dutasteride Pellets | 0.25, 0.333, 0.5 | Class-II | 5-alpha reductase inhibitor |
| 7 | Fenofibrate Pellets | 56, 66.23 | Class-II | Antilipemic agents |
| 8 | Itraconazole Pellets | 20, 22, 27.5, 30, 32.25, 32.5, 35, 40, 44, 60 | Class-II | Broad-spectrum triazole antifungal agent |
| 9 | Mebeverine Pellets | 40 | Class-I | Antispasmodic |
| 10 | Orlistat Pellets | 40, 50, 60 | Class-II | Anti-obesity agent |
| 11 | Rosuvastatin Pellets | 7.5, 10, 15 | Class-II | HMG-CoA reductase inhibitor |
| Delayed Release Pellets | ||||
| 1 | Aspirin Pellets | 40, 45, 52.653, 55.5, 60 | Class-I | NSAID |
| 2 | Dexlansoprazole Pellets | 15, 17, 20, 22, 22.5, 23, 25 | Class-II | Proton pump inhibitor (PPI) |
| 3 | Duloxetine HCl Pellets | 9, 12, 17, 20, 22.5, 25 | Class-II | SNRI |
| 4 | Esomeprazole Mg. Pellets | 8.5, 11, 15, 17, 22, 22.5, 27.1, 27.24 | Class-II | Proton pump inhibitor (PPI) |
| 5 | Lansoprazole Pellets | 8.5, 9, 9.25, 10, 11.2, 12, 12.5, 14 | Class-II | Proton pump inhibitor (PPI) |
| 6 | Omeprazole Pellets | 8.5, 9, 10, 20, 30 | Class-II | Proton pump inhibitor (PPI) |
| 7 | Pantoprazole Sodium Pellets | 15, 16, 20, 21.62, 22, 22.5 | Class-III | Proton pump inhibitor (PPI) |
| 8 | Rabeprazole Sodium Pellets | 7.3, 7.5, 8, 10, 14.3, 15, 20, 22.5 | Class-III | Proton pump inhibitor (PPI) |
| Dual Delayed Release Pellets | ||||
| 1 | Dexlansoprazole Pellets | 15, 17, 20, 22, 22.5, 23, 25 | Class-II | Proton pump inhibitor (PPI) |
| Extended Release Pellets | ||||
| 1 | Venlafaxine HCl Pellets | 30, 33, 35, 39, 50 | Class-I | SNRI |
| Sustain Release Pellets | ||||
| 1 | Aceclofenac Pellets | 60 | Class-II | NSAID |
| 2 | Cinitapride Pellets | 1.45 | Class-II | Gastroprokinetic agent |
| 3 | Diclofenac Sodium Pellets | 33, 40 | Class-II | NSAID |
| 4 | Galantamine HBr Pellets | 8 | Class-I | Cholinesterase inhibitor |
| 5 | Indomethacin Pellets | 10, 27.5, 30 | Class-II | NSAID |
| 6 | Ketoprofen Pellets | 70 | Class-II | NSAID |
| 7 | Mebeverine Pellets | 40, 46, 80 | Class-I | Antispasmodic |
| 8 | Nitroglycerine Pellets | 1.136, 1.4, 2.5 | Class-I | Nitrate vasodilator |
| 9 | Tamsulosin HCl Pellets | 0.12, 0.113, 0.125, 0.16, 0.20, 0.267 | Class-II | Alpha-1 adrenergic blockers |
| 10 | Itopride Pellets | 50 | Class-I | Gastroprokinetic agent |